Gene · 8694
Papers2,292
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,292
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sulforaphane ameliorates bisphenol A-induced hepatic lipid accumulation by inhibiting endoplasmic reticulum stress. | Sci Rep | 2023 | 36670177 | PubTator, text mining | PubMed |
| Discovery of benzochromene derivatives first example with dual cytotoxic activity against the resistant cancer cell MCF-7/ADR and inhibitory effect of the P-glycoprotein expression levels. | J Enzyme Inhib Med Chem | 2023 | 36662632 | PubTator, text mining | PubMed |
| The growth, lipid accumulation and adaptation mechanism in response to variation of temperature and nitrogen supply in psychrotrophic filamentous microalga Xanthonema hormidioides (Xanthophyceae). | Biotechnol Biofuels Bioprod | 2023 | 36658609 | PubTator, text mining | PubMed |
| TMT-based quantitative proteomic analysis reveals the underlying mechanisms of glycidyl methacrylate-induced 16HBE cell malignant transformation. | Toxicology | 2023 | 36641056 | PubTator, text mining | PubMed |
| Lysophosphatidylcholine inhibits lung cancer cell proliferation by regulating fatty acid metabolism enzyme long-chain acyl-coenzyme A synthase 5. | Clin Transl Med | 2023 | 36639836 | PubTator, text mining | PubMed |
| Control of tumor-associated macrophage responses by nutrient acquisition and metabolism. | Immunity | 2023 | 36630912 | PubTator, text mining | PubMed |
| BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells. | J Exp Clin Cancer Res | 2023 | 36604676 | PubTator, text mining | PubMed |
| DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. | Cell Rep Med | 2023 | 36603576 | PubTator, text mining | PubMed |
| S1PR1/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma. | J Exp Clin Cancer Res | 2023 | 36600310 | PubTator, text mining | PubMed |
| Targeting fatty acid metabolism in glioblastoma. | J Clin Invest | 2023 | 36594473 | PubTator, text mining | PubMed |
| Lactic acidosis induces metabolic and phenotypic reprogramming in cholangiocarcinoma cells via the upregulation of thrombospondin-1. | Cancer Sci | 2023 | 36562400 | PubTator, text mining | PubMed |
| The association of fasting plasma thiol fractions with body fat compartments, biomarker profile, and adipose tissue gene expression. | Amino Acids | 2023 | 36542145 | PubTator, text mining | PubMed |
| Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment - Cell Type-Specific Findings (Part 2). | Curr Allergy Asthma Rep | 2023 | 36520269 | PubTator, text mining | PubMed |
| Humulus lupus extract rich in xanthohumol improves the clinical course in critically ill COVID-19 patients. | Biomed Pharmacother | 2023 | 36508996 | PubTator, text mining | PubMed |
Corrigendum to "Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization" [Redox Biol. 56 (2022) 102452]. | Redox Biol | 2023 | 36481115 | PubTator, text mining | PubMed |
| Characterization of pig skeletal muscle transcriptomes in response to low temperature. | Vet Med Sci | 2023 | 36480456 | PubTator, text mining | PubMed |
| The genetics of monogenic intestinal epithelial disorders. | Hum Genet | 2023 | 36422736 | PubTator, text mining | PubMed |
| DGAT1 mutation in two sisters with failure to thrive: a case report. | Arch Argent Pediatr | 2023 | 36315449 | PubTator, text mining | PubMed |
| Rosiglitazone Reverses Inflammation in Epididymal White Adipose Tissue in Hormone-Sensitive Lipase-Knockout Mice. | J Lipid Res | 2023 | 36273647 | PubTator, text mining | PubMed |
| A look into DGAT1 through the EM lenses. | Biochim Biophys Acta Biomembr | 2023 | 36216097 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8694/papers?page=21